TMCnet

Eisai Completes Rolling Submission to US FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced ...
Le Lézard

Eisai Completes Rolling Submission to U.S. FDA for LEQEMBI® IQLIKtm (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that Eisai has completed the rolling submission of the Supplemental Biologics License Application (sBLA ...
Analytics Insight

Best New Crypto to Buy Now: Breakout Projects With 20x–50x Potential

The crypto market in late 2025 is still full of sharp swings, but that has not stopped serious crypto investors from hunting for the best new crypto to buy now.

Kirkland Lake Discoveries Begins Fully Funded 25,000-m Drill Program; Appoints VP Exploration & Technical Advisor

Kirkland Lake Discoveries (TSXV: KLDC) (OTCID: KLKLF) ("KLDC" or the "Company") is pleased to announce the commencement of ...

OceanaGold Extends High-Grade Mineralization at Wharekirauponga and Receives Draft Decision and Conditions to Approve the Waihi North Project

OceanaGold Corporation (TSX: OGC) (OTCQX: OCANF) ("OceanaGold" or the "Company") announces results from ten drill holes from ...